{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:04:22Z","timestamp":1789967062641,"version":"4.0.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic obstructive pulmonary disease (COPD) is characterized by persistent airway inflammation, epithelial barrier dysfunction, and progressive structural remodeling. Although glycocalyx impairment has been implicated in COPD pathogenesis, the mechanisms linking glycocalyx degradation to epithelial barrier injury remain incompletely understood. Heparanase (HPSE), the only mammalian endoglycosidase capable of degrading heparan sulfate, may contribute to COPD progression by regulating epithelial glycocalyx integrity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      HPSE expression was evaluated in serum samples from patients with COPD, a murine COPD model induced by cigarette smoke exposure combined with lipopolysaccharide (LPS), and cigarette smoke extract (CSE)-stimulated human bronchial epithelial BEAS-2B cells. The therapeutic effects of CV122, a small-molecule heparanase inhibitor previously developed by our group, were investigated\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      using assessments of lung function, histopathology, inflammatory cytokine production, epithelial permeability, glycocalyx integrity, junctional protein expression, and Akt\/NF-\u03baB signaling activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HPSE abundance, including the mature 50-kDa HPSE form, was increased in serum from patients with COPD, lung tissues of COPD mice, and CSE-stimulated epithelial cells. In the murine COPD model, CV122 treatment significantly improved pulmonary function, reduced inflammatory cytokine production, and attenuated emphysematous and fibrotic remodeling. Mechanistically, CV122 preserved epithelial glycocalyx integrity, restored the expression and localization of ZO-1, occludin, and E-cadherin, and reduced epithelial and vascular permeability. In addition, CV122 inhibited Akt and NF-\u03baB pathway activation, accompanied by decreased levels of TNF-\u03b1, IL-1\u03b2, and IL-6. Consistently, CV122 protected BEAS-2B cells against CSE-induced apoptosis, cytotoxicity, inflammatory responses, and barrier dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identifies HPSE-associated glycocalyx remodeling as an important contributor to epithelial barrier dysfunction in COPD. Pharmacological inhibition of HPSE with CV122 preserves glycocalyx integrity, restores epithelial barrier function, and attenuates inflammatory signaling, at least in part through suppression of the Akt\/NF-\u03baB pathway. These findings advance our understanding of glycocalyx remodeling in COPD and support HPSE as a promising therapeutic target for disease modification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1934045","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:28:03Z","timestamp":1789964883000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting heparanase-associated epithelial glycocalyx remodeling attenuates Akt\/NF-\u03baB\u2013related barrier dysfunction in experimental COPD"],"prefix":"10.3389","volume":"17","author":[{"given":"Yueping","family":"Bai","sequence":"first","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]},{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Industry-Academia-Research Collaborative and Innovation Center for Intelligent Rehabilitation Drug R&D of Shandong Province, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Health and Life Sciences, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xushan","family":"Ma","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhen","family":"Jin","sequence":"additional","affiliation":[{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Industry-Academia-Research Collaborative and Innovation Center for Intelligent Rehabilitation Drug R&D of Shandong Province, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Health and Life Sciences, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Song","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Zeng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]},{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Industry-Academia-Research Collaborative and Innovation Center for Intelligent Rehabilitation Drug R&D of Shandong Province, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Health and Life Sciences, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Fang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]},{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Industry-Academia-Research Collaborative and Innovation Center for Intelligent Rehabilitation Drug R&D of Shandong Province, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Health and Life Sciences, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Industry-Academia-Research Collaborative and Innovation Center for Intelligent Rehabilitation Drug R&D of Shandong Province, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Health and Life Sciences, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Yang","sequence":"additional","affiliation":[{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Industry-Academia-Research Collaborative and Innovation Center for Intelligent Rehabilitation Drug R&D of Shandong Province, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Health and Life Sciences, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]},{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Industry-Academia-Research Collaborative and Innovation Center for Intelligent Rehabilitation Drug R&D of Shandong Province, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Health and Life Sciences, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1165\/rcmb.2017-0200TR","article-title":"Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure","volume":"58","author":"Aghapour","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","article-title":"Global burden of chronic obstructive pulmonary disease through 2050","volume":"6","author":"Boers","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"250110","DOI":"10.1183\/16000617.0110-2025","article-title":"A translational view of airway epithelial dysfunction in COPD","volume":"34","author":"Brightling","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1164\/rccm.202407-1379ci","article-title":"Current smoker: a clinical chronic obstructive pulmonary disease phenotype affecting disease progression and response to therapy","volume":"211","author":"Celli","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12974-017-0912-8","article-title":"Heparanase promotes neuroinflammatory response during subarachnoid hemorrhage in rats","volume":"14","author":"Changyaleket","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","article-title":"The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020\u201350: a health-augmented macroeconomic modelling study","volume":"11","author":"Chen","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3390\/cells11132035","article-title":"Heparanase expression propagates liver damage in CCL4-Induced mouse model","volume":"11","author":"Cheng","year":"2022","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/s0140-6736(22)00470-6","article-title":"Chronic obstructive pulmonary disease","volume":"399","author":"Christenson","year":"2022","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-17-0242","article-title":"Aspirin inhibits cancer metastasis and angiogenesis via targeting heparanase","volume":"23","author":"Dai","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"112154","DOI":"10.1016\/j.jclinane.2026.112154","article-title":"Endothelial glycocalyx in perioperative medicine current understanding and future direction","volume":"110","author":"Farag","year":"2026","journal-title":"J. Clin. Anesth."},{"key":"B11","doi-asserted-by":"publisher","first-page":"156878","DOI":"10.1016\/j.phymed.2025.156878","article-title":"Pulmonary microvascular endothelial glycocalyx degradation as a key driver in COPD progression and its protection by tongxinluo","volume":"143","author":"Guo","year":"2025","journal-title":"Phytomedicine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","article-title":"Regulation of immune responses by the airway epithelial cell landscape","volume":"21","author":"Hewitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1183\/09031936.00141514","article-title":"The innate immune function of airway epithelial cells in inflammatory lung disease","volume":"45","author":"Hiemstra","year":"2015","journal-title":"Eur. Respir. J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"100131","DOI":"10.1016\/j.pharmr.2026.100131","article-title":"Epithelial cells in chronic obstructive pulmonary disease exacerbations: targets for lung repair","volume":"78","author":"Ji","year":"2026","journal-title":"Pharmacol. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"111026","DOI":"10.1016\/j.biopha.2020.111026","article-title":"Alveolar epithelial glycocalyx shedding aggravates the epithelial barrier and disrupts epithelial tight junctions in acute respiratory distress syndrome","volume":"133","author":"Li","year":"2021","journal-title":"Biomed. and Pharmacother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/ptr.8104","article-title":"Formononetin attenuates cigarette smoke\u2010induced COPD in mice by suppressing inflammation, endoplasmic reticulum stress, and apoptosis in bronchial epithelial cells via AhR\/CYP1A1 and AKT\/mTOR signaling pathways","volume":"38","author":"Li","year":"2024","journal-title":"Phytotherapy Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"116977","DOI":"10.1016\/j.intimp.2026.116977","article-title":"Targeting heparanase-mediated glycocalyx degradation as a novel strategy to inhibit EMT-Driven pulmonary fibrosis","volume":"185","author":"Li","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12967-015-0538-5","article-title":"Impact of heparanase on renal fibrosis","volume":"13","author":"Masola","year":"2015","journal-title":"J. Transl. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"124255","DOI":"10.1016\/j.carbpol.2025.124255","article-title":"Low-molecular-weight dextran sulfate sodium as novel heparanase inhibitor preventing breast cancer metastasis in mice by inhibiting migration and angiogenesis","volume":"369","author":"Mo","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"B20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.tcb.2026.01.004","article-title":"Epithelial barrier homeostasis","volume":"36","author":"Otani","year":"2026","journal-title":"Trends in Cell Biology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrneph.2017.6","article-title":"Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease","volume":"13","author":"Rabelink","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1201658","DOI":"10.3389\/fimmu.2023.1201658","article-title":"Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD","volume":"14","author":"Raby","year":"2023","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"123717","DOI":"10.1016\/j.biomaterials.2025.123717","article-title":"Reprogramming the glycocalyx: advances in glycoengineering for immunomodulation and regenerative medicine","volume":"326","author":"Rana","year":"2026","journal-title":"Biomaterials"},{"key":"B24","doi-asserted-by":"publisher","first-page":"121979","DOI":"10.1016\/j.carbpol.2024.121979","article-title":"Rational synthesis of a heparan sulfate saccharide that promotes the activity of BMP2","volume":"333","author":"Shaffer","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"B25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40265-025-02188-8","article-title":"Chronic obstructive pulmonary disease (COPD): developments in pharmacological treatments","volume":"85","author":"Singh","year":"2025","journal-title":"Drugs"},{"key":"B26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/s0140-6736(22)01273-9","article-title":"Towards the elimination of chronic obstructive pulmonary disease: a lancet commission","volume":"400","author":"Stolz","year":"2022","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2301619","DOI":"10.1183\/13993003.01619-2023","article-title":"Airway remodelling in asthma and the epithelium: on the edge of a new era","volume":"63","author":"Varricchi","year":"2024","journal-title":"Eur. Respir. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drup.2016.10.001","article-title":"Heparanase: from basic research to therapeutic applications in cancer and inflammation","volume":"29","author":"Vlodavsky","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"B29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-020-00345-x","article-title":"Progress in the mechanism and targeted drug therapy for COPD","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2403337","DOI":"10.1002\/advs.202403337","article-title":"A novel drug candidate for sepsis targeting heparanase by inhibiting cytokine storm","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"119150","DOI":"10.1016\/j.jep.2024.119150","article-title":"Ethanol extracts of Cinnamomum migao H.W. li attenuates neuroinflammation in cerebral ischemia-reperfusion injury via regulating TLR4-PI3K-Akt-NF-\u03baB pathways","volume":"339","author":"Wu","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"14428","DOI":"10.3390\/ijms232214428","article-title":"Morusin protected ruminal epithelial cells against lipopolysaccharide-induced inflammation through inhibiting EGFR-AKT\/NF-\u03baB signaling and improving barrier functions","volume":"23","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"103793","DOI":"10.1016\/j.redox.2025.103793","article-title":"Arylsulfatase K attenuates airway epithelial cell senescence in COPD by regulating parkin-mediated mitophagy","volume":"86","author":"Yang","year":"2025","journal-title":"Redox Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2000404","DOI":"10.1183\/13993003.00404-2020","article-title":"Cigarette smoke-initiated autoimmunity facilitates sensitisation to elastin-induced COPD-Like pathologies in mice","volume":"56","author":"Zhou","year":"2020","journal-title":"Eur. Respir. J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrm.2016.80","article-title":"Tight junctions: from simple barriers to multifunctional molecular gates","volume":"17","author":"Zihni","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1934045\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:28:04Z","timestamp":1789964884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1934045\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":35,"alternative-id":["10.3389\/fphar.2026.1934045"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1934045","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1934045"}}